List of Contents

Cell-based Assays Market Size, Share, and Trends 2024 to 2033

Cell-based Assays Market (By Type: Cell Viability Assay, Cytotoxicity Assay, Cell Death Assay, Cell Proliferation Assay, Other; By Products & Services: Reagents, Assay Kits, Microplates, Probes & Labels, Instruments & Software, Cell Lines; By Application: Basic Research, Drug Discovery, Other; By Technology: Automated Handling, Flow Cytometry, Label-free Detection, High-throughput Screening, Others; By End-use) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

  • Last Updated : April 2024
  • Report Code : 2982
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Cell-based Assays Market 

5.1. COVID-19 Landscape: Cell-based Assays Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Cell-based Assays Market, By Type

8.1. Cell-based Assays Market, by Type, 2024-2033

8.1.1. Cell Viability Assay

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Cytotoxicity Assay

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Cell Death Assay

8.1.3.1. Market Revenue and Forecast (2021-2033)

8.1.4. Cell Proliferation Assay

8.1.4.1. Market Revenue and Forecast (2021-2033)

8.1.5. Others

8.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Cell-based Assays Market, By Products & Services

9.1. Cell-based Assays Market, by Products & Services, 2024-2033

9.1.1. Reagents

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Assay Kits

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Microplates

9.1.3.1. Market Revenue and Forecast (2021-2033)

9.1.4. Probes & Labels

9.1.4.1. Market Revenue and Forecast (2021-2033)

9.1.5. Instruments & Software

9.1.5.1. Market Revenue and Forecast (2021-2033)

9.1.6. Cell Lines

9.1.6.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Cell-based Assays Market, By Application 

10.1. Cell-based Assays Market, by Application, 2024-2033

10.1.1. Basic Research

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Drug Discovery

10.1.2.1. Market Revenue and Forecast (2021-2033)

10.1.3. Other Applications

10.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Cell-based Assays Market, By Technology

11.1. Cell-based Assays Market, by Technology, 2024-2033

11.1.1. Automated Handling

11.1.1.1. Market Revenue and Forecast (2021-2033)

11.1.2. Flow Cytometry

11.1.2.1. Market Revenue and Forecast (2021-2033)

11.1.3. Label-free Detection

11.1.3.1. Market Revenue and Forecast (2021-2033)

11.1.4. High-throughput Screening

11.1.4.1. Market Revenue and Forecast (2021-2033)

11.1.5. Others

11.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 12. Global Cell-based Assays Market, By End-use

12.1. Cell-based Assays Market, by End-use, 2024-2033

12.1.1. Pharmaceutical and Biotechnology Companies

12.1.1.1. Market Revenue and Forecast (2021-2033)

12.1.2. Academic & Government Institutes

12.1.2.1. Market Revenue and Forecast (2021-2033)

12.1.3. Contract Research Organizations

12.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 13. Global Cell-based Assays Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Type (2021-2033)

13.1.2. Market Revenue and Forecast, by Products & Services (2021-2033)

13.1.3. Market Revenue and Forecast, by Application (2021-2033)

13.1.4. Market Revenue and Forecast, by Technology (2021-2033)

13.1.5. Market Revenue and Forecast, by End-use (2021-2033)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Type (2021-2033)

13.1.6.2. Market Revenue and Forecast, by Products & Services (2021-2033)

13.1.6.3. Market Revenue and Forecast, by Application (2021-2033)

13.1.6.4. Market Revenue and Forecast, by Technology (2021-2033)

13.1.6.5. Market Revenue and Forecast, by End-use (2021-2033) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Type (2021-2033)

13.1.7.2. Market Revenue and Forecast, by Products & Services (2021-2033)

13.1.7.3. Market Revenue and Forecast, by Application (2021-2033)

13.1.7.4. Market Revenue and Forecast, by Technology (2021-2033)

13.1.7.5. Market Revenue and Forecast, by End-use (2021-2033)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Type (2021-2033)

13.2.2. Market Revenue and Forecast, by Products & Services (2021-2033)

13.2.3. Market Revenue and Forecast, by Application (2021-2033)

13.2.4. Market Revenue and Forecast, by Technology (2021-2033) 

13.2.5. Market Revenue and Forecast, by End-use (2021-2033) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Type (2021-2033)

13.2.6.2. Market Revenue and Forecast, by Products & Services (2021-2033)

13.2.6.3. Market Revenue and Forecast, by Application (2021-2033)

13.2.7. Market Revenue and Forecast, by Technology (2021-2033) 

13.2.8. Market Revenue and Forecast, by End-use (2021-2033) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Type (2021-2033)

13.2.9.2. Market Revenue and Forecast, by Products & Services (2021-2033)

13.2.9.3. Market Revenue and Forecast, by Application (2021-2033)

13.2.10. Market Revenue and Forecast, by Technology (2021-2033)

13.2.11. Market Revenue and Forecast, by End-use (2021-2033)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Type (2021-2033)

13.2.12.2. Market Revenue and Forecast, by Products & Services (2021-2033)

13.2.12.3. Market Revenue and Forecast, by Application (2021-2033)

13.2.12.4. Market Revenue and Forecast, by Technology (2021-2033)

13.2.13. Market Revenue and Forecast, by End-use (2021-2033)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Type (2021-2033)

13.2.14.2. Market Revenue and Forecast, by Products & Services (2021-2033)

13.2.14.3. Market Revenue and Forecast, by Application (2021-2033)

13.2.14.4. Market Revenue and Forecast, by Technology (2021-2033)

13.2.15. Market Revenue and Forecast, by End-use (2021-2033)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Type (2021-2033)

13.3.2. Market Revenue and Forecast, by Products & Services (2021-2033)

13.3.3. Market Revenue and Forecast, by Application (2021-2033)

13.3.4. Market Revenue and Forecast, by Technology (2021-2033)

13.3.5. Market Revenue and Forecast, by End-use (2021-2033)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Type (2021-2033)

13.3.6.2. Market Revenue and Forecast, by Products & Services (2021-2033)

13.3.6.3. Market Revenue and Forecast, by Application (2021-2033)

13.3.6.4. Market Revenue and Forecast, by Technology (2021-2033)

13.3.7. Market Revenue and Forecast, by End-use (2021-2033)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Type (2021-2033)

13.3.8.2. Market Revenue and Forecast, by Products & Services (2021-2033)

13.3.8.3. Market Revenue and Forecast, by Application (2021-2033)

13.3.8.4. Market Revenue and Forecast, by Technology (2021-2033)

13.3.9. Market Revenue and Forecast, by End-use (2021-2033)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Type (2021-2033)

13.3.10.2. Market Revenue and Forecast, by Products & Services (2021-2033)

13.3.10.3. Market Revenue and Forecast, by Application (2021-2033)

13.3.10.4. Market Revenue and Forecast, by Technology (2021-2033)

13.3.10.5. Market Revenue and Forecast, by End-use (2021-2033)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Type (2021-2033)

13.3.11.2. Market Revenue and Forecast, by Products & Services (2021-2033)

13.3.11.3. Market Revenue and Forecast, by Application (2021-2033)

13.3.11.4. Market Revenue and Forecast, by Technology (2021-2033)

13.3.11.5. Market Revenue and Forecast, by End-use (2021-2033)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Type (2021-2033)

13.4.2. Market Revenue and Forecast, by Products & Services (2021-2033)

13.4.3. Market Revenue and Forecast, by Application (2021-2033)

13.4.4. Market Revenue and Forecast, by Technology (2021-2033)

13.4.5. Market Revenue and Forecast, by End-use (2021-2033)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Type (2021-2033)

13.4.6.2. Market Revenue and Forecast, by Products & Services (2021-2033)

13.4.6.3. Market Revenue and Forecast, by Application (2021-2033)

13.4.6.4. Market Revenue and Forecast, by Technology (2021-2033)

13.4.7. Market Revenue and Forecast, by End-use (2021-2033)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Type (2021-2033)

13.4.8.2. Market Revenue and Forecast, by Products & Services (2021-2033)

13.4.8.3. Market Revenue and Forecast, by Application (2021-2033)

13.4.8.4. Market Revenue and Forecast, by Technology (2021-2033)

13.4.9. Market Revenue and Forecast, by End-use (2021-2033)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Type (2021-2033)

13.4.10.2. Market Revenue and Forecast, by Products & Services (2021-2033)

13.4.10.3. Market Revenue and Forecast, by Application (2021-2033)

13.4.10.4. Market Revenue and Forecast, by Technology (2021-2033)

13.4.10.5. Market Revenue and Forecast, by End-use (2021-2033)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Type (2021-2033)

13.4.11.2. Market Revenue and Forecast, by Products & Services (2021-2033)

13.4.11.3. Market Revenue and Forecast, by Application (2021-2033)

13.4.11.4. Market Revenue and Forecast, by Technology (2021-2033)

13.4.11.5. Market Revenue and Forecast, by End-use (2021-2033)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Type (2021-2033)

13.5.2. Market Revenue and Forecast, by Products & Services (2021-2033)

13.5.3. Market Revenue and Forecast, by Application (2021-2033)

13.5.4. Market Revenue and Forecast, by Technology (2021-2033)

13.5.5. Market Revenue and Forecast, by End-use (2021-2033)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Type (2021-2033)

13.5.6.2. Market Revenue and Forecast, by Products & Services (2021-2033)

13.5.6.3. Market Revenue and Forecast, by Application (2021-2033)

13.5.6.4. Market Revenue and Forecast, by Technology (2021-2033)

13.5.7. Market Revenue and Forecast, by End-use (2021-2033)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Type (2021-2033)

13.5.8.2. Market Revenue and Forecast, by Products & Services (2021-2033)

13.5.8.3. Market Revenue and Forecast, by Application (2021-2033)

13.5.8.4. Market Revenue and Forecast, by Technology (2021-2033)

13.5.8.5. Market Revenue and Forecast, by End-use (2021-2033)

Chapter 14. Company Profiles

14.1. Danaher Corporation

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Lonza Group AG

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Promega Corporation

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. F. Hoffmann-La Roche AG

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Charles River Laboratories International, Inc.

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Menarini Silicon Biosystems, Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Becton, Dickinson and Company

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Bio-Rad Laboratories, Inc.

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Macrogen Inc

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. DiscoverX Corporation

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us